Ovarian teratoma-associated anti-NMDA receptor encephalitis with severe features
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is rare but diagnosable via CSF IgG antibodies. This case highlights successful treatment with surgery and immunotherapy for a young woman with an ovarian teratoma.
Area Of Science
- Neurology
- Immunology
- Oncology
Background
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an uncommon autoimmune neurological disorder.
- Diagnosis relies on detecting cerebrospinal fluid (CSF) IgG antibodies targeting NMDAR subunits (GluN1 and GluN2).
Observation
- A young woman presented with clinical manifestations of anti-NMDAR encephalitis.
- An ovarian teratoma, a known potential trigger, was identified in the patient.
Findings
- Cerebrospinal fluid analysis confirmed the presence of IgG antibodies against NMDAR subunits.
- The patient's ovarian teratoma was surgically resected.
- Multiple immunomodulatory therapies were administered as part of the treatment regimen.
Implications
- This case underscores the importance of recognizing anti-NMDAR encephalitis in clinical practice.
- Early diagnosis and prompt treatment, including tumor resection and immunotherapy, are crucial for favorable outcomes.
- Ovarian teratomas should be considered in the differential diagnosis of anti-NMDAR encephalitis in women.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.